Having demonstrated that the genes in the IPF mortality score can be re-weighted to create an ILA score, and that this ILA score [IPF transcripts] consistently associates with ILA and time-to-death in two cohorts, we sought to understand how biological processes annotated to the IPF mortality genes relate to our outcomes. The gene discussed is TNFRSF9; the disease is idiopathic pulmonary fibrosis.